Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

NCT05768139

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +40 more
Locations
  • Ellison Clinic at Saint John's Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 65 locations
View Trial Details
Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

NCT04892173

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California at San Diego Moores Cancer Center La Jolla, California, United States
  • Memorial Radiation Oncology Medical Group Laguna Hills Laguna Hills, California, United States
View all 191 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

NCT07136545

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations
  • Chang-Gung Memorial Hospital(Lin-Kou) Taoyuan, Guishan District, Taiwan
  • National Taiwan University Hospital Taipei, Taipei City, Taiwan
  • Taipei Veterans General Hospital Taipei, Taipei City, Taiwan
View Trial Details
Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

NCT06385080

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • University of California at San Diego Moores Cancer Center La Jolla, California, United States
  • University of Colorado Denver Anschultz Medical Campus Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 56 locations
View Trial Details
Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

NCT07276399

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Providence St Jude Medical Center Fullerton, California, United States
  • Scripps Health La Jolla, California, United States
View all 196 locations
View Trial Details
Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • START New York Long Island Lake Success, New York, United States
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
View Trial Details
Recruiting

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

NCT05522881

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
View Trial Details

Related conditions